Evidence map›Paper›PMID 31788413›Full record

ArticleCurrent pulmonology reports2019

Central Sleep Apnea: a Brief Review.

M Safwan Badr, John D Dingell, Shahrokh Javaheri

Abstract read
In one paragraph

Article in Current pulmonology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Sleep, Neural Circulatory Control, and Cardiovascular Disease: A Mechanistic Review.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Insights, recommendations, and research priorities for central sleep apnea: report from an expert panel.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Sleep Apnea and Heart Failure-Current State-of-The-Art.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Peripheral Chemoreceptor Activity in Infants Less than 29 Weeks of Gestation?American journal of respiratory and critical care medicine · 2023
    Article
  20. Central Sleep Apnea in Adults: Diagnosis and Treatment.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M Safwan BadrDepartment of Internal Medicine, Division of pulmonary, critical; care and sleep medicine.
John D DingellWayne State University School of Medicine.
Shahrokh JavaheriSleep Laboratory, Bethesda North Hospital, Cincinnati, OH.
Bethesda North Hospital · USWayne State University · US

Funding

CENTRAL SLEEP APNEA--ROLE OF LONGTERM FACILITATIONR01HL053443 · NHLBI · WAYNE STATE UNIVERSITY · PI BADR, M.SAFWAN · 1999 to 2009
$1.8M
Sleep-Disordered Breathing in patients with C-SCI: Mechanisms and TherapyR01HL130552 · NHLBI · WAYNE STATE UNIVERSITY · PI BADR, M.SAFWAN · 2016 to 2020
$1.5M
Sleep and Breathing in Patients With Spinal Cord InjuryI01CX001040 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI BADR, M.SAFWAN · 2014 to 2017
–
CSRD VA I01 CX001040NHLBI NIH HHS R01 HL053443NHLBI NIH HHS R01 HL130552
6 · The paper itself

Abstract

purposeThe purpose of this review is to discuss the pathogenesis, clinical manifestations, diagnosis and treatment, including areas of controversy and uncertainty. RECENT

findingsCentral apnea may be due to hypoventilation or to hypocapnia following hyperventilation. The occurrence of central apnea initiates a cascade of events that perpetuates breathing instability, recurrent central apnea and upper airway narrowing. In fact, breathing instability and upper airway narrowing are key elements of central and obstructive apnea. Clinically, central apnea is noted in association with obstructive sleep apnea, heart failure, atrial fibrillation, cerebrovascular accidents tetraplegia, and chronic opioid use.Management strategy for central apnea aim to eliminate abnormal respiratory events, stabilize sleep and alleviate the underlying clinical condition. Positive pressure therapy (PAP) remains a standard therapy for central as well as obstructive apnea. Other treatment options include adaptive-servo ventilation (ASV), supplemental oxygen, phrenic nerve stimulation, and pharmacologic therapy. However, ASV is contraindicated in patients with central sleep apnea who had heart failure with reduced ejection fraction, owing to increased mortality in this population. SUMMARY: There are several therapeutic options for central apnea. Randomized controlled studies are needed to ascertain the long-term effectiveness of individual, or combination, treatment modalities in different types of central apnea.

Indexed as

adaptive-Servo ventilationBPAPCentral apneaCPAPheart failureopioidpositive-pressure therapysleep

Identifiers

PMID31788413
PMCPMC6883649
OpenAlexW2921811120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.